Mirjam Kohls

• [ 2025 ]
• [ 2024 ]
• [ 2023 ]
• [ 2022 ]
• [ 2021 ]

• 1.

  Bonifacio E, Coelho R, Ewald DA, Gemulla G, Hubmann M, Jarosz-Chobot P, Kohls M, Kordonouri O, Lampasona V, Narendran P, Pociot F, Šumník Z, Szypowska A, Zapardiel-Gonzalo J, Ziegler AG. The efficacy of islet autoantibody screening with or without genetic pre-screening strategies for the identification of presymptomatic type 1 diabetes. Diabetologia. 2025;68(6):1101-7.
  • [ DOI ]
• 1.

  Huber E, Singh T, Bunk M, Hebel M, Kick K, Weiß A, Kohls M, Köger M, Hergl M, Zapardiel Gonzalo JM, Bonifacio E, Ziegler AG. Discrimination and Precision of Continuous Glucose Monitoring in Staging Children With Presymptomatic Type 1 Diabetes. J Clin Endocrinol Metab. 2025;110(6):1624-32.
  • [ DOI ]
• 1.

  Hoffmann L, Kohls M, Arnolds S, Achenbach P, Bergholdt R, Bonifacio E, Bosi E, Gündert M, Hoefelschweiger BK, Hummel S, Jarosz-Chobot P, Kordonouri O, Lampasona V, Narendran P, Overbergh L, Pociot F, Raposo JF, Šumník Z, Szypowska A, Vercauteren J, Winkler C, Mathieu C, Ziegler AG. EDENT1FI Master Protocol for screening of presymptomatic early-stage type 1 diabetes in children and adolescents. BMJ Open. 2025;15(1):e088522.
  • [ DOI ]

• 1.

  Appel KS, Lee CH, Nunes de Miranda SM, Maier D, Reese JP, Anton G, Bahmer T, Ballhausen S, Balzuweit B, Bellinghausen C, Blumentritt A, Brechtel M, Chaplinskaya-Sobol I, Erber J, Fiedler K, Geisler R, Heyder R, Illig T, Kohls M, Kollek J, Krist L, Lorbeer R, Miljukov O, Mitrov L, Nürnberger C, Pape C, Pley C, Schäfer C, Schaller J, Schattschneider M, Scherer M, Schulze N, Stahl D, Stubbe HC, Tamminga T, Tebbe JJ, Vehreschild MJGT, Wiedmann S, Vehreschild JJ. A precise performance-based reimbursement model for the multi-centre NAPKON cohorts – development and evaluation. Scientific Reports [Internet]. 2024;14(1):13607. Available from: https://doi.org/10.1038/s41598-024-63945-5
  • [ DOI ]
• 1.

  Weiß M, Gutzeit J, Appel KS, Bahmer T, Beutel M, Deckert J, Fricke J, Hanß S, Hettich-Damm N, Heuschmann PU, Horn A, Jauch-Chara K, Kohls M, Krist L, Lorenz-Depiereux B, Otte C, Pape D, Reese JP, Schreiber S, Störk S, Vehreschild JJ, Hein G. Depression and fatigue six months post-COVID-19 disease are associated with overlapping symptom constellations: A prospective, multi-center, population-based cohort study. J Affect Disord. 2024;352:296-305.
  • [ DOI ]
• 1.

  Lange B, Jaeger VK, Harries M, Rücker V, Streeck H, Blaschke S, Petersmann A, Toepfner N, Nauck M, Hassenstein MJ, Dreier M, von Holt I, Budde A, Bartz A, Ortmann J, Kurosinski MA, Berner R, Borsche M, Brandhorst G, Brinkmann M, Budde K, Deckena M, Engels G, Fenzlaff M, Härtel C, Hovardovska O, Katalinic A, Kehl K, Kohls M, Krüger S, Lieb W, Meyer-Schlinkmann KM, Pischon T, Rosenkranz D, Rübsamen N, Rupp J, Schäfer C, Schattschneider M, Schlegtendal A, Schlinkert S, Schmidbauer L, Schulze-Wundling K, Störk S, Tiemann C, Völzke H, Winter T, Klein C, Liese J, Brinkmann F, Ottensmeyer PF, Reese JP, Heuschmann P, Karch A. Estimates of protection levels against SARS-CoV-2 infection and severe COVID-19 in Germany before the 2022/2023 winter season: the IMMUNEBRIDGE project. Infection. 2024;52(1):139-53.
  • [ DOI ]
• 1.

  Appel KS, Nurnberger C, Bahmer T, Forster C, Polidori MC, Kohls M, Kraus T, Hettich-Damm N, Petersen J, Blaschke S, Brohl I, Butzmann J, Dashti H, Deckert J, Dreher M, Fiedler K, Finke C, Geisler R, Hanses F, Hopff SM, Jensen BO, Konik M, Lehnert K, de Miranda SMN, Mitrov L, Miljukov O, Reese JP, Rohde G, Scherer M, Tausche K, Tebbe JJ, Vehreschild JJ, Voit F, Wagner P, Weigl M, Lemhofer C. Definition of the Post-COVID syndrome using a symptom-based Post-COVID score in a prospective, multi-center, cross-sectoral cohort of the German National Pandemic Cohort Network (NAPKON). Infection [Internet]. 2024;. Available from: https://www.ncbi.nlm.nih.gov/pubmed/38587752
  • [ DOI ]

• 1.

  Engels G, Oechsle AL, Schlegtendal A, Maier C, Holzwarth S, Streng A, Lange B, Karch A, Petersmann A, Streeck H, Blaschke-Steinbrecher S, Härtel C, Schroten H, von Kries R, Berner R, Liese J, Brinkmann F, Toepfner N. SARS-CoV-2 sero-immunity and quality of life in children and adolescents in relation to infections and vaccinations: the IMMUNEBRIDGE KIDS cross-sectional study, 2022. Infection. 2023;51(5):1531-9.
  • [ DOI ]
• 1.

  Yusuf KO, Miljukov O, Schoneberg A, Hanß S, Wiesenfeldt M, Stecher M, Mitrov L, Hopff SM, Steinbrecher S, Kurth F, Bahmer T, Schreiber S, Pape D, Hofmann AL, Kohls M, Störk S, Stubbe HC, Tebbe JJ, Hellmuth JC, Erber J, Krist L, Rieg S, Pilgram L, Vehreschild JJ, Reese JP, Krefting D. Consistency as a Data Quality Measure for German Corona Consensus Items Mapped from National Pandemic Cohort Network Data Collections. Methods Inf Med. 2023;62(S 01):e47-e56.
  • [ DOI ]
• 1.

  Weiß M, Gründahl M, Deckert J, Eichner FA, Kohls M, Störk S, Heuschmann PU, Hein G. Differential network interactions between psychosocial factors, mental health, and health-related quality of life in women and men. Sci Rep. 2023;13(1):11642.
  • [ DOI ]

• 1.

  Lemhöfer C, Appel KS, Häuser W, Hettich N, Kohls M, Polidori MC. Post-COVID: Alles eine Frage der Definition? [Post COVID - Just a matter of definition?]. DMW-Deutsche Medizinische Wochenschrift. 2022;147(21):1391-7.
  • [ DOI ]
• 1.

  Kohls M, Freisling H, Charvat H, Soerjomataram I, Viallon V, Davila-Batista V, Kaaks R, Turzanski-Fortner R, Aleksandrova K, Schulze MB, Dahm CC, Tilma Vistisen H, Rostgaard-Hansen AL, Tjønneland A, Bonet C, Sánchez MJ, Colorado-Yohar S, Masala G, Palli D, Krogh V, Ricceri F, Rolandsson O, Lu SSM, Tsilidis KK, Weiderpass E, Gunter MJ, Ferrari P, Berger U, Arnold M. Impact of cumulative body mass index and cardiometabolic diseases on survival among patients with colorectal and breast cancer: a multi-centre cohort study. BMC Cancer. 2022;22(1):546.
  • [ DOI ]
• 1.

  Lange B, Jäger VK, Rücker V, Harries M, Hassenstein MJ, Dreier M, von Holt I, Budde A, Kurosinski MA, Armann J, Bartz A, Berner R, Brandhorst G, Brinkmann M, Budde K, Deckena M, Engels G, Fenzlaff M, Härtel C, Hovardovska O, Kehl K, Kohls M, Krüger S, Meyer-Schlinkmann KM, Ottensmeyer PF, Reese JP, Rosenkranz D, Rübsamen N, Schlegtendal A, Schattschneider M, Schäfer C, Schlinkert S, Schulze-Wundling K, Störk S, Tiemann C, Völzke H, Winter T, Liese J, Brinkmann F, Heuschmann P, Nauck M, Petersmann A, Blaschke-Steinbrecher S, Toepfner N, Streeck H, Karch A. 2. Interimsanalyse des IMMUNEBRIDGE-Projektes zur Kommunikation von vorläufigen Ergebnissen an das Modellierungsnetz für schwere Infektionskrankheiten. Zenodo. 2022;.
  • [ DOI ]
• 1.

  Lange B, Jäger V, Rücker V, Hassenstein M, Harries M, Berner R, Blaschke-Steinbrecher S, Brandhorst G, Budde K, Fenzlaff M, Rosenkranz D, Schattschneider M, Schäfer C, Streeck H, Winter T, Nauck M, Petersmann A, Töpfner N, Heuschmann P, Karch A. Interimsanalyse des IMMUNEBRIDGE-Projektes zur Kommunikation von vorläufigen Ergebnissen an die Modellierungskonsortien der BMBF-geförderten Modellierungsplattform. Zenodo. 2022;.
  • [ DOI ]
• 1.

  Bahmer T, Borzikowsky C, Lieb W, Horn A, Krist L, Fricke J, Scheibenbogen C, Rabe KF, Maetzler W, Maetzler C, Laudien M, Frank D, Ballhausen S, Hermes A, Miljukov O, Haeusler KG, Mokhtari NEE, Witzenrath M, Vehreschild JJ, Krefting D, Pape D, Montellano FA, Kohls M, Morbach C, Störk S, Reese JP, Keil T, Heuschmann P, Krawczak M, Schreiber S. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study. EClinicalMedicine. 2022;51:101549.
  • [ DOI ]
• 1.

  Schons M, Pilgram L, Reese JP, Stecher M, Anton G, Appel KS, Bahmer T, Bartschke A, Bellinghausen C, Bernemann I, Brechtel M, Brinkmann F, Brünn C, Dhillon C, Fiessler C, Geisler R, Hamelmann E, Hansch S, Hanses F, Hanß S, Herold S, Heyder R, Hofmann AL, Hopff SM, Horn A, Jakob C, Jiru-Hillmann S, Keil T, Khodamoradi Y, Kohls M, Kraus M, Krefting D, Kunze S, Kurth F, Lieb W, Lippert LJ, Lorbeer R, Lorenz-Depiereux B, Maetzler C, Miljukov O, Nauck M, Pape D, Püntmann V, Reinke L, Römmele C, Rudolph S, Sass J, Schäfer C, Schaller J, Schattschneider M, Scheer C, Scherer M, Schmidt S, Schmidt J, Seibel K, Stahl D, Steinbeis F, Störk S, Tauchert M, Tebbe JJ, Thibeault C, Toepfner N, Ungethüm K, Vadasz I, Valentin H, Wiedmann S, Zoller T, Nagel E, Krawczak M, von Kalle C, Illig T, Schreiber S, Witzenrath M, Heuschmann P, Vehreschild JJ. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics. Eur J Epidemiol. 2022;37(8):849-70.
  • [ DOI ]
• 1.

  Herrmann J, Lotz C, Karagiannidis C, Weber-Carstens S, Kluge S, Putensen C, Wehrfritz A, Schmidt K, Ellerkmann RK, Oswald D, Lotz G, Zotzmann V, Moerer O, Kühn C, Kochanek M, Muellenbach R, Gaertner M, Fichtner F, Brettner F, Findeisen M, Heim M, Lahmer T, Rosenow F, Haake N, Lepper PM, Rosenberger P, Braune S, Kohls M, Heuschmann P, Meybohm P. Key characteristics impacting survival of COVID-19 extracorporeal membrane oxygenation. Crit Care. 2022;26(1):190.
  • [ DOI ]
• 1.

  Koll CEM, Hopff SM, Meurers T, Lee CH, Kohls M, Stellbrink C, Thibeault C, Reinke L, Steinbrecher S, Schreiber S, Mitrov L, Frank S, Miljukov O, Erber J, Hellmuth JC, Reese JP, Steinbeis F, Bahmer T, Hagen M, Meybohm P, Hansch S, Vadász I, Krist L, Jiru-Hillmann S, Prasser F, Vehreschild JJ. Statistical biases due to anonymization evaluated in an open clinical dataset from COVID-19 patients. Sci Data. 2022;9(1):776.
  • [ DOI ]

• 1.

  Horn A, Krist L, Lieb W, Montellano FA, Kohls M, Haas K, Gelbrich G, Bolay-Gehrig SJ, Morbach C, Reese JP, Störk S, Fricke J, Zoller T, Schmidt S, Triller P, Kretzler L, Rönnefarth M, Von Kalle C, Willich SN, Kurth F, Steinbeis F, Witzenrath M, Bahmer T, Hermes A, Krawczak M, Reinke L, Maetzler C, Franzenburg J, Enderle J, Flinspach A, Vehreschild J, Schons M, Illig T, Anton G, Ungethüm K, Finkenberg BC, Gehrig MT, Savaskan N, Heuschmann PU, Keil T, Schreiber S. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP). Infection. 2021;49(6):1277-8.
  • [ DOI ]
• 1.

  Lee L, Mou F, Um Boock A, Fellinghauer C, Kohls M, Cieza A, Sabariego C. Identifying key environmental barriers experienced by persons with mild, moderate, or severe disability in Bankim Health District, Cameroon: a policy-targeted secondary analysis of data obtained with the World Bank and WHO model disability survey. Arch Public Health. 2021;79(1):95.
  • [ DOI ]